Reza Ghiasvand

Reza Ghiasvand

Auto-generated profile, based on publicly available information

Reza Ghiasvand

Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2022 in International Journal of Cancer
Verified
Journal Article
Open access
YMYahya Mahamat‐Saleh
Yahya Mahamat‐Saleh
MAMarie Al‐Rahmoun
Marie Al‐Rahmoun
GSGianluca Severi
Gianluca Severi
RGReza Ghiasvand
Reza Ghiasvand
MVMarit B Veierød
Marit B Veierød
MKMarina Kvaskoff
Marina Kvaskoff
Experimental evidence suggests that alcohol induces cutaneous carcinogenesis, yet epidemiological studies on the link between alcohol intake and skin cancer have been inconsistent. The European Prospective Investigation into Cancer and Nutrition (EPIC) is a prospective cohort initiated in 1992 in 10 European countries. Alcohol intake at baseline and average lifetime alcohol intake were assessed using validated country‐specific dietary and lifestyle questionnaires. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated in Cox models. A total of 14 037 skin cancer cases (melanoma: n = 2457; basal‐cell carcinoma (BCC): n = 8711; squamous‐cell carcinoma (SCC): n = 1928; unknown: n = 941) were identified among 450 112 participants (average follow‐up: 15 years). Baseline alcohol intake was positively associated with SCC (>15 vs 0.1‐4.9 g/day: HR = 1.44, 95% CI = 1.17‐1.77; Ptrend = .001), BCC (HR = 1.12, 95% CI = 1.01‐1.23; Ptrend = .04), and melanoma risks in men (HR = 1.17, 95% CI = 0.95‐1.44; Ptrend = .17), while associations were more modest in women (SCC: HR = 1.09, 95% CI = 0.90‐1.30; Ptrend = .13; BCC: HR = 1.08, 95% CI = 1.00‐1.17, Ptrend = .03; melanoma: HR = 0.93, 95% CI = 0.80‐1.08, Ptrend = .13). Associations were similar for lifetime alcohol intake, with an attenuated linear trend. Lifetime liquor/spirit intake was positively associated with melanoma (fourth vs first quartile: HR = 1.47, 95% CI = 1.08‐1.99; Ptrend = .0009) and BCC risks in men (HR = 1.17, 95% CI = 1.04‐1.31; Ptrend = .14). Baseline and lifetime intakes of wine were associated with BCC risk (HR = 1.25 in men; HR = 1.11‐1.12; in women). No statistically significant associations were found between beverage types and SCC risk. Intake of beer was not associated with skin cancer risk. Our study suggests positive relationships between alcohol intake and skin cancer risk, which may have important implications for the primary prevention of skin cancer.

10 September 2019 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
ICIris Cervenka
Iris Cervenka
MRMarie Al Rahmoun
Marie Al Rahmoun
YMYahya Mahamat‐Saleh
Yahya Mahamat‐Saleh
AFAgnès Fournier
Agnès Fournier
MBMarie-christine Boutron-Ruault
Marie-christine Boutron-Ruault
MKMarina Kvaskoff
Marina Kvaskoff
Evidence suggests an influence of sex hormones on cutaneous melanoma risk, but epidemiologic findings are conflicting. We examined the associations between use of oral contraceptives (OCs) and menopausal hormone therapy (MHT) and melanoma risk in women participating in the European Prospective Investigation into Cancer and Nutrition (EPIC). EPIC is a prospective cohort study initiated in 1992 in 10 European countries. Information on exogenous hormone use at baseline was derived from country‐specific self‐administered questionnaires. We used Cox proportional hazards regression models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). Over 1992–2015, 1,696 melanoma cases were identified among 334,483 women, whereof 770 cases among 134,758 postmenopausal women. There was a positive, borderline‐significant association between OC use and melanoma risk (HR = 1.12, 95% CI = 1.00–1.26), with no detected heterogeneity across countries (phomogeneity = 0.42). This risk increased linearly with duration of use (ptrend = 0.01). Among postmenopausal women, ever use of MHT was associated with a nonsignificant increase in melanoma risk overall (HR = 1.14, 95% CI = 0.97–1.43), which was heterogeneous across countries (phomogeneity = 0.05). Our findings do not support a strong and direct association between exogenous hormone use and melanoma risk. In order to better understand these relations, further research should be performed using prospectively collected data including detailed information on types of hormone, and on sun exposure, which may act as an important confounder or effect modifier on these relations.

22 December 2022 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
LBLeon A M Berge
Leon A M Berge
FLFei-Chih Liu
Fei-Chih Liu
TGTom K Grimsrud
Tom K Grimsrud
RBRonnie Babigumira
Ronnie Babigumira
NSNathalie C Støer
Nathalie C Støer
JSJo S Stenehjem
Jo S Stenehjem
Night shift work may acutely disrupt the circadian rhythm, with possible carcinogenic effects. Prostate cancer has few established risk factors though night shift work, a probable human carcinogen, may increase the risk. We aimed to study the association between night shift work and chlorinated degreasing agents (CDAs) as possible endocrine disrupters in relation to aggressive prostate cancer as verified malignancies. We conducted a case-cohort study on 299 aggressive prostate cancer cases and 2056 randomly drawn non-cases in the Norwegian Offshore Petroleum Workers cohort (1965–98) with linkage to the Cancer Registry of Norway (1953–2019). Work history was recorded as years with day, night, and rollover (rotating) shift work, and CDA exposure was assessed with expert-made job-exposure matrices. Weighted Cox regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for aggressive prostate cancer, adjusted for education and year of first employment, stratified by 10-year birth cohorts, and with 10, 15, and 20 years of exposure lag periods. Compared with day work only, an increased hazard of aggressive prostate cancer (HR = 1.86, 95% CI 1.18–2.91; P-trend = 0.046) was found in workers exposed to ≥19.5 years of rollover shift work. This persisted with longer lag periods (HR = 1.90, 95% CI 0.92–3.95; P-trend = 0.007). The exposure-hazard curve for a non-linear model increased linearly (HRs ≥1.00) for 18–26 years of rollover shift work. No association was found with CDA exposure. Long-term exposure to rollover shift work may increase the hazard of aggressive prostate cancer in offshore petroleum workers.

1 May 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
MRMarie Al Rahmoun
Marie Al Rahmoun
RGReza Ghiasvand
Reza Ghiasvand
MCManon Cairat
Manon Cairat
YMYahya Mahamat-Saleh
Yahya Mahamat-Saleh
ICIris Cervenka
Iris Cervenka
AFAgnès Fournier
Agnès Fournier

4 February 2019 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
Mostafa DianatinasabMostafa Dianatinasab
Mostafa Dianatinasab
MFMohammad Fararouei
Mohammad Fararouei
NDNima Daneshi
Nima Daneshi
SRShahab Rezaeian
Shahab Rezaeian
MMMohammad Mohammadianpanah
Mohammad Mohammadianpanah
RGReza Ghiasvand
Reza Ghiasvand

22 December 2022 in Clinical Epidemiology
Verified
Journal Article
Open access
PDF file
FPFlavie Perrier
Flavie Perrier
RGReza Ghiasvand
Reza Ghiasvand
SLSimon Lergenmuller
Simon Lergenmuller
TRTrude Eid Robsahm
Trude Eid Robsahm
AGAdele C Green
Adele C Green
MVMarit B Veierød
Marit B Veierød
Purpose: Physical activity (PA) is a cornerstone in disease prevention and varies throughout life. A pooled analysis of cohort studies and a meta-analysis of cohort studies found positive associations between PA and melanoma risk. However, previous studies focused on PA at specific ages and often lacked information on ultraviolet radiation (UVR) exposure. Using the population-based Norwegian Women and Cancer (NOWAC) cohort, including information on PA and UVR exposure, we estimated life-course PA trajectories from adolescence to adulthood and their associations with melanoma. Methods: Total PA across different domains (recreation, occupation, transport, household) was reported for ages 14 and 30 years, and when responding to the questionnaire (31– 76 years) using a 10-point scale, validated to rank PA levels in Norwegian females. We estimated life-course PA trajectories using a latent class mixed model in 152,248 women divided into three subcohorts depending on age at questionnaire completion: 31– 39 (n = 27,098), 40– 49 (n = 52,515) and ≥ 50 years (n = 72,635). The unique 11-digit identity number of Norwegian citizens was used to link NOWAC to the Cancer Registry of Norway for information on cancer diagnoses, emigration and death. Associations between PA trajectories and melanoma risk were estimated in each subcohort using multivariable Cox regression. Results: Five classes of individual life-course PA trajectories were identified in subcohort 31– 39 years (low, moderate, high, decreasing, increasing PA) and four in subcohorts 40– 49 and ≥ 50 years (low, moderate, high, decreasing PA). No significant association was found between life-course PA trajectories and melanoma risk in any subcohort. Hazard ratios (95% confidence intervals) for the high versus moderate trajectory were 0.92 (0.66– 1.29), 1.15 (0.97– 1.37) and 0.90 (0.78– 1.05) for subcohorts 31– 39, 40– 49 and ≥ 50 years, respectively. Conclusion: Our results do not support a positive association between PA and melanoma risk found in previous studies, which is important for public health guidelines promoting regular PA.